Peptide Therapy
DIHEXA
Is a first-in-class compound that is orally active, penetrates the blood-brain barrier, and facilitates memory consolidation and retrieval. This angiotensin-based small molecule may be efficacious as a treatment for neurodegenerative diseases.
This small molecule was derived from the pre-prototype molecule Nle1-angiotensin IV. It has shown promise in facilitating the formation of new functional synaptic connections and augmenting memory consolidation.
How does DIHEXA work?
The therapeutic value of this approach lies in its capacity to encourage the formation of new functional synaptic connections among existing neurons, encourage the replacement of damaged and lost neurons from available neural stem cell populations and facilitate cerebral blood flow and neuroprotection. Such treatment outcomes would benefit patients afflicted with AD and possibly those suffering from other neurodegenerative diseases.
What Are the Benefits of DIHEXA?
- Improved cognitive function.
- Helps in the treatment of Alzheimer’s.
- Helps in the treatment of Parkinson’s.
- Improves short and long-term memory.
- Helps manage depression.
- Enhances creative thinking.
- Improves brain focus.